VRG Therapeutics (VRG Tx) is a VC-backed pioneering biopharmaceutical R&D company with a world-class AI-driven drug discovery platform. Our mission is to cure diseases via targets and mechanisms of actions (MoAs) that cannot be reached with traditional approaches.

VRG Therapeutics (VRG Tx) (https://vrgtherapeutics.com) is a pioneering biopharmaceutical R&D company headquartered in Budapest, Hungary. VRG Tx has a continuously growing R&D portfolio focused on innovative miniprotein-peptide based pharmaceuticals and Cell and Gene Therapy (CGT) research programs. We are building a world-class AI-driven drug discovery platform with a singular mission: to cure diseases by targeting biological mechanisms that are inaccessible to traditional therapeutic approaches. Our discovery engine integrates machine learning, physics-based modeling, and experimental validation to design novel protein therapeutics.